MedTrace Logo

A Registered Cohort Study on α-Synucleinopathy

NCT05527067 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2023-03-23

No results posted yet for this study

Summary

α-Synucleinopathy is a cluster of neurodegenerative disease with motor and non-motor symptom. The data to be collected is intended to help healthcare providers make important medical decisions concerning α-synucleinopathy, through an enhanced understanding of the natural history, progression and multi-omics datasets of α-synucleinopathy.

Conditions

  • α-synucleinopathy

Interventions

OTHER

Data collection

Neuropsychological assessment, brain MRI, electroencephalogram and biomarker datas will be collected

OTHER

Data collection

Neuropsychological assessment, brain MRI, electroencephalogram and biomarker datas will be collected

Sponsors & Collaborators

  • Fujian Medical University Union Hospital

    lead OTHER

Eligibility

Min Age
30 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-09-01
Primary Completion
2030-06-30
Completion
2030-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05527067 on ClinicalTrials.gov